News from advaite inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Mar 18, 2021, 09:00 ET ADVAITE Now Offers FDA EUA RapCov™ Rapid COVID-19 Tests Through Amazon Business

ADVAITE's RapCov™ Rapid COVID-19 Test, one of the first US manufactured FDA EUA authorized point-of-care (PoC) serology tests, is now available via...

Jan 12, 2021, 07:30 ET FDA GRANTS ADVAITE EMERGENCY USE AUTHORIZATION FOR RapCov™ Rapid COVID-19 Test

The U.S. Food and Drug Administration has granted Emergency Use Authorization (EUA) to one of the first U.S.-manufactured serology tests designed by...

Dec 08, 2020, 11:01 ET Rýchlotest RapCovTM na COVID-19 od spoločnosti ADVAITE prešiel certifikáciou a získal známku CE

ADVAITE Inc., inovatívne biotechnologická firma, ktorá sa zaoberá vývojom moderných diagnostických testov, dnes oznámila, že jej rýchlotest RapCovTM...

Dec 07, 2020, 07:58 ET ADVAITE otrzymała certyfikat CE na test RapCov™ Rapid COVID-19

ADVAITE Inc., nowatorska firma biotechnologiczna, koncentrująca się na opracowywaniu nowych testów diagnostycznych dla punktów opieki, ogłosiła...

Dec 07, 2020, 03:04 ET Rychlotest RapCov™ na COVID-19 společnosti ADVAITE prošel certifikací a získal značku CE

ADVAITE Inc., inovativní biotechnologická firma, která se zabývá vývojem moderních diagnostických testů, dnes oznámila, že její rychlotest RapCov™ na ...

Dec 07, 2020, 02:52 ET ADVAITE reçoit le marquage CE pour son test COVID-19 rapide RapCov™

ADVAITE Inc., une société de biotechnologie innovante qui se concentre sur le développement de nouveaux tests de diagnostic sur le lieu de soin, a...

Dec 07, 2020, 02:44 ET ADVAITE erhält CE-Kennzeichnungsfreigabe für seinen RapCov™ COVID-19-Schnelltest

ADVAITE Inc., eine innovative Biotech-Firma, die sich auf die Entwicklung neuer diagnostischer Point-of-Care-Tests konzentriert, gab heute bekannt,...

Dec 07, 2020, 02:24 ET ADVAITE получает разрешение CE Mark для своей системы экспресс-тестирования на COVID-19 RapCov™

Инновационная биотехнологическая компания ADVAITE Inc., специализирующаяся на разработке новых средств диагностического тестирования на местах,...

Dec 07, 2020, 01:55 ET ADVAITE recibe el permiso de la Marca CE para su test rápido de la COVID-19, RapCov™

ADVAITE Inc., innovadora compañía de biotecnología centrada en los nuevos test de desarrollo de diagnosis de punto de cuidado, anunció que ha...

Nov 11, 2020, 09:00 ET ADVAITE's High Complexity CLIA Lab Receives Authorization from Yale University to Offer Highly Accurate COVID-19 SalivaDirect™ Test

ADVAITE Inc., a biotech at the forefront of the COVID-19 pandemic response, announces that the company's high complexity CLIA laboratory operating...

Apr 07, 2020, 09:43 ET Advaite Deploys COVID-19 Rapid Antibody Test Kits To Chester County And Collaborates With Pennsylvania Companies To Scale Up Manufacturing

Advaite, an innovative biotech company focused on developing novel diagnostics, announced today that it has delivered antibody rapid test kits to...

Mar 12, 2020, 13:41 ET Advaite Produces COVID-19 Rapid Response Diagnostic Testing Kits

Advaite, an innovative biotech company focused on developing novel diagnostics, announced today that it will begin supplying the global market with...

Dec 09, 2019, 11:38 ET Advaite Inc. Enters into Exclusive License Option Agreement with the George Washington University for Novel AMES Negative HDAC6 Inhibitor Technology

Advaite Inc., a Chicago, IL based oncology-focused biotech company developing novel therapeutics and diagnostics to help patients suffering from...